SK
Surya Kiran Reddy Konda
About Surya Kiran Reddy Konda
Data last updated:
Surya Kiran Reddy Konda is a Director at Reddy Pharmaceuticals Limited (since 2023) and Director at Kiom Pharmaceuticals (Opc) Private Limited (since 2025). The companies operate in Pharma and Paper. The largest current company by reported revenue is Reddy Pharmaceuticals Limited at ₹1.05 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Reddy Pharmaceuticals Limited U24232TG1996PLC116710 | Director | 30 Sep 2023 | 1996 | ₹1.05 Cr (FY 2024) | Active |
 Kiom Pharmaceuticals (Opc) Private Limited U21000TS2025OPC192626 | Director | 04 Jan 2025 | 2025 | Active |
Board colleagues of Surya Kiran Reddy Konda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Konda Raghurami Reddy | 02487006 | Reddy Pharmaceuticals Limited , Kiom Pharmaceuticals (Opc) Private Limited | Director |
| Vishnu Vardhan Reddy Konda | 07417632 | Reddy Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surya Kiran Reddy Konda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surya Kiran Reddy Konda
Surya Kiran Reddy Konda currently holds 2 directorships: Reddy Pharmaceuticals Limited (Director, since 30 Sep 2023, revenue ₹1.05 Cr (FY 2024)); Kiom Pharmaceuticals (Opc) Private Limited (Director, since 04 Jan 2025).
Surya Kiran Reddy Konda was first appointed on 30 Sep 2023 as Director at Reddy Pharmaceuticals Limited. The most recent appointment on record is 04 Jan 2025 at Kiom Pharmaceuticals (Opc) Private Limited.
The current boards of Surya Kiran Reddy Konda's companies include Konda Raghurami Reddy (Reddy Pharmaceuticals Limited), Vishnu Vardhan Reddy Konda (Reddy Pharmaceuticals Limited).